← Back to Search

Face Recognition Training for Face Blindness

N/A
Recruiting
Led By Joseph DeGutis, Ph.D.
Research Sponsored by Boston VA Research Institute, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, within 2 weeks post-training (approximately 10 weeks after baseline), 12 weeks after training ends (approximately 22 weeks after baseline)
Awards & highlights

Study Summary

This trial will test new training methods to improve face processing in people with developmental prosopagnosia. Subjects will be randomly assigned one of three treatments.

Who is the study for?
This trial is for adults aged 18-90 with lifelong difficulties in recognizing faces, impacting daily life. They must perform poorly on specific face recognition tests. Excluded are those with severe cognitive impairments, psychiatric disorders like schizophrenia or major depression, substance dependence, recent behavioral interventions, or significant neurological disorders.Check my eligibility
What is being tested?
The study compares two experimental training programs designed to improve face processing abilities in people with developmental prosopagnosia against an active control group. Participants will be randomly assigned to one of three groups: perception training, memory training, or placebo control.See study design
What are the potential side effects?
As this trial involves non-medical interventions (training programs), there are no direct medical side effects expected. However, participants may experience fatigue or frustration during the exercises.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, within 2 weeks post-training (approximately 10 weeks after baseline), 12 weeks after training ends (approximately 22 weeks after baseline)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, within 2 weeks post-training (approximately 10 weeks after baseline), 12 weeks after training ends (approximately 22 weeks after baseline) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Cambridge Face Memory Test from baseline to post-training
Change in Face Perception from baseline to post-training
Secondary outcome measures
Change in Eye processing ability from baseline to post-training
Change in Face Recollection from baseline to post-training
Change in Holistic processing from baseline to post-training
+2 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Placebo Group
Group I: Memory TrainingExperimental Treatment1 Intervention
Participants will perform 6 weeks of face memory training (5 x 40 min sessions/week) that targets enhancing encoding to improve face recollection. As training progresses, the repetition lags (spaces between repeated foil faces) and number of faces will increase.
Group II: Perception TrainingActive Control1 Intervention
Participants will perform 6 weeks of face perception training (5 x 40 min sessions/week) that require discriminating faces based on internal features (e.g., eyebrow-eye distance). As training progresses, the faces will become more challenging and the face sizes will vary.
Group III: Active Control TrainingPlacebo Group1 Intervention
Participants will perform 6 weeks of face perception training (5 x 40 min sessions/week) that require discriminating faces based on external facial features (e.g., hair). As training progresses, the faces will become more challenging and the face sizes will vary.

Find a Location

Who is running the clinical trial?

Boston VA Research Institute, Inc.Lead Sponsor
22 Previous Clinical Trials
10,734 Total Patients Enrolled
Joseph DeGutis, Ph.D.Principal InvestigatorHarvard Medical School/VA Boston Healthcare Systems

Media Library

Face Memory Training Clinical Trial Eligibility Overview. Trial Name: NCT05800782 — N/A
Face Blindness Research Study Groups: Memory Training, Perception Training, Active Control Training
Face Blindness Clinical Trial 2023: Face Memory Training Highlights & Side Effects. Trial Name: NCT05800782 — N/A
Face Memory Training 2023 Treatment Timeline for Medical Study. Trial Name: NCT05800782 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this clinical trial accept participants aged 45 and below?

"This clinical trial permits participants aged 18 to 90, as per their inclusion criteria."

Answered by AI

Am I eligible to partake in the experiment?

"In order to be considered for this clinical trial, patients must suffer from prosopagnosia and range in age between 18 and 90. The recruitment of 72 participants is currently underway."

Answered by AI

What are the desired results of this clinical research?

"This clinical trial will track patient progress over baseline, 10 weeks after the start of experimentation and 22 weeks afterward. The primary goal is to measure changes in face perception from pre-intervention to post-treatment. Secondary goals include assessing self-reported facial recognition skills, eye processing ability with Georges task and holistic advantage from part-whole analysis."

Answered by AI

Is there still an opportunity to participate in this clinical experiment?

"The trial is inactive as per clinicaltrials.gov, with its initial posting on April 15th 2023 and the last update made 4 days later. Despite this inactivity, there are 2 other trials that require participants at present."

Answered by AI

Who else is applying?

What site did they apply to?
VA Boston Healthcare System
What portion of applicants met pre-screening criteria?
Met criteria

Why did patients apply to this trial?

Recent research and studies
clinicaltrials.govStudy
Face Perception vs. Memory Training to Improve Face Recognition in Developmental Prosopagnosia
2023. "Face Perception vs. Memory Training to Improve Face Recognition in Developmental Prosopagnosia". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05800782.
~43 spots leftby Feb 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top